Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Targeted medical therapy of biliary tract cancer: recent advances and future perspectives Hopfner M; Schuppan D; Scherubl HWorld J Gastroenterol 2008[Dec]; 14 (46): 7021-32The limited efficacy of cytotoxic therapy for advanced biliary tract and gallbladder cancers emphasizes the need for novel and more effective medical treatment options. A better understanding of the specific biological features of these neoplasms led to the development of new targeted therapies, which take the abundant expression of several growth factors and cognate tyrosine kinase receptors into account. This review will briefly summarize the status and future perspectives of antiangiogenic and growth factor receptor-based pharmacological approaches for the treatment of biliary tract and gallbladder cancers. In view of multiple novel targeted approaches, the rationale for innovative therapies, such as combinations of growth factor (receptor)-targeting agents with cytotoxic drugs or with other novel anticancer drugs will be highlighted.|Angiogenesis Inhibitors/therapeutic use[MESH]|Antibodies, Monoclonal/pharmacology/therapeutic use[MESH]|Antineoplastic Agents/*therapeutic use[MESH]|Biliary Tract Neoplasms/*drug therapy[MESH]|Cytotoxins/therapeutic use[MESH]|Drug Delivery Systems/*trends[MESH]|Humans[MESH]|Receptors, Growth Factor/drug effects[MESH] |